AlphaGrep UK’s Stryker SYK Stock Holding History

AlphaGrep UK’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,383	Closed	-$454K	–	946
2026 Q1	$454K	Sell	1,383 -1,592	-54%	-$572K	0.13%	298
2025 Q4	$1.05M	Buy	+2,975	New	+$1.08M	0.35%	27

Other funds holding SYK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

AlphaGrep UK's SYK Position: Q2 2026 in Review

AlphaGrep UK sold out of Stryker (SYK) in Q2 2026, closing a stake of 1,383 shares — an estimated $454K sold.

AlphaGrep UK first reported a position in SYK in Q4 2025 and held it in 2 quarters. The position peaked at $1.05M in Q4 2025. 2,156 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

AlphaGrep UK reported no remaining Stryker position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 1,383 Stryker shares in Q2 2026, an estimated $454K.
AlphaGrep UK first reported a position in Stryker in Q4 2025 and held it in 2 quarters.
AlphaGrep UK's Stryker position peaked at $1.05M in Q4 2025.
2,156 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.